Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Phosphoserine aminotransferase 1 is associated to poor outcome on tamoxifen therapy in recurrent breast cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-05-12
DOI
10.1038/s41598-017-02296-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Unknown
- (2017) Aging-US
- Reprogramming metabolism by histone methyltransferase NSD2 drives endocrine resistance via coordinated activation of pentose phosphate pathway enzymes
- (2016) Junjian Wang et al. CANCER LETTERS
- Endocrine therapy resistance in estrogen receptor (ER)-positive breast cancer
- (2016) Tommaso De Marchi et al. DRUG DISCOVERY TODAY
- IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth
- (2015) Katherine T. Venmar et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Genomic profiling of CHEK2*1100delC-mutated breast carcinomas
- (2015) Maarten P. G. Massink et al. BMC CANCER
- The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours
- (2015) S J Thomas et al. BRITISH JOURNAL OF CANCER
- 4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer
- (2015) Tommaso De Marchi et al. Molecular Oncology
- Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells
- (2015) Yu Mi Woo et al. PLoS One
- High protein expression of EZH2 is related to unfavorable outcome to tamoxifen in metastatic breast cancer
- (2014) E. A. Reijm et al. ANNALS OF ONCOLOGY
- Epigenetic alterations in endocrine-related cancer
- (2014) Sandra Rodríguez-Rodero et al. ENDOCRINE-RELATED CANCER
- Integrative analysis of cancer imaging readouts by networks
- (2014) Marco Dominietto et al. Molecular Oncology
- Serine and glycine metabolism in cancer
- (2014) Ivano Amelio et al. TRENDS IN BIOCHEMICAL SCIENCES
- Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer
- (2013) E. Burandt et al. BREAST CANCER RESEARCH AND TREATMENT
- Tamoxifen resistance: From bench to bedside
- (2013) Marjolein Droog et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- ESR1 ligand-binding domain mutations in hormone-resistant breast cancer
- (2013) Weiyi Toy et al. NATURE GENETICS
- Abundant expression of interleukin-21 receptor in follicular lymphoma cells is associated with more aggressive disease
- (2012) Brianne Wood et al. LEUKEMIA & LYMPHOMA
- How cancer metabolism is tuned for proliferation and vulnerable to disruption
- (2012) Almut Schulze et al. NATURE
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration
- (2012) Douglas G. Altman et al. PLOS MEDICINE
- Interleukin 21 impairs tumor immunosurveillance of colitis-associated colorectal cancer
- (2012) Rebecca Kesselring et al. OncoImmunology
- Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
- (2011) Richard Possemato et al. NATURE
- Phosphoglycerate dehydrogenase diverts glycolytic flux and contributes to oncogenesis
- (2011) Jason W Locasale et al. NATURE GENETICS
- Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control
- (2011) H Jäkel et al. ONCOGENE
- Frozen robust multiarray analysis (fRMA)
- (2010) M. N. McCall et al. BIOSTATISTICS
- KEGG for representation and analysis of molecular networks involving diseases and drugs
- (2009) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search